Privatt, Sara R.
Braga, Camila Pereira
Johnson, Alicia
Lidenge, Salum J.
Berry, Luke
Ngowi, John R.
Ngalamika, Owen
Chapple, Andrew G.
Mwaiselage, Julius
Wood, Charles
West, John T.
Adamec, Jiri
Article History
Received: 12 April 2023
Accepted: 22 August 2023
First Online: 31 August 2023
Declarations
:
: Informed consent was obtained from all subjects involved in this study. This study was approved by the review boards of Tanzania National Institute for Medical Research, Ocean Road Cancer Institute, the University of Zambia Biomedical Research Ethics Committee, and the University of Nebraska-Lincoln (UNL) under protocol code 2261, effective 6 July 2022.
: All study participants signed a written consent document after consultation with a clinical recruiter, indicating a willingness for their deidentified bio-specimens to be included in downstream research activities.
: The authors declare that they have no competing interests.